ATHE – alterity therapeutics limited - american depositary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

ATHE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/4

07:51 am

athe

Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor [Yahoo! Finance]

Neutral Report

Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor [Yahoo! Finance]

Report

3/4

07:25 am

athe

Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor

Neutral Report

Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor

Report

3/2

08:01 am

athe

Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments [Yahoo! Finance]

Low Report

Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments [Yahoo! Finance]

Report

3/2

07:25 am

athe

Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments

Low Report

Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments

Report

2/14

06:24 am

athe

Alterity Therapeutics (NASDAQ:ATHE) was upgraded by analysts at Zacks Research to a "hold" rating.

Low Report

Alterity Therapeutics (NASDAQ:ATHE) was upgraded by analysts at Zacks Research to a "hold" rating.

Report

1/30

07:43 am

athe

Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update [Yahoo! Finance]

Medium Report

Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update [Yahoo! Finance]

Report

1/30

07:25 am

athe

Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update

Low Report

Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update

Report

1/21

07:25 am

athe

Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026

Medium Report

Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026

Report

Date

Time

Symbol

Company Name

Action

%Chg

Date

Time

Action

From

Firm

Impact

%Chg

12/17

07:51 am

Initiates

Speculative Buy

Canaccord Genuity

Medium

Report

-4.9%

Report

12/17

07:18 am

Initiates

SPECULATIVE BUY

CANACCORD

Medium

Report

-4.9%

Report

Date

Time

Symbol

Headline

Impact

3/4

06:04 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Mar 04

Medium Report

Form 6-K ALTERITY THERAPEUTICS For: Mar 04

Report

2/26

06:02 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Dec 31

Low Report

Form 6-K ALTERITY THERAPEUTICS For: Dec 31

Report

1/30

08:00 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Jan 30

Medium Report

Form 6-K ALTERITY THERAPEUTICS For: Jan 30

Report

1/21

06:05 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Jan 21

Medium Report

Form 6-K ALTERITY THERAPEUTICS For: Jan 21

Report

1/15

06:32 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Jan 15

Low Report

Form 6-K ALTERITY THERAPEUTICS For: Jan 15

Report

1/15

06:29 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Jan 15

Low Report

Form 6-K ALTERITY THERAPEUTICS For: Jan 15

Report

1/13

08:00 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Jan 13

Medium Report

Form 6-K ALTERITY THERAPEUTICS For: Jan 13

Report

1/7

08:02 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Jan 07

Neutral Report

Form 6-K ALTERITY THERAPEUTICS For: Jan 07

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.